Meeting
2018 Gastrointestinal Cancers Symposium
Association of tumor infiltrating CD8 positive T cells and PDL-1 expression with survival after conversion surgery for unresectable gastric cancer.
Authors
Hiroaki Tanaka
Osaka City University Graduate School of Medicine, Osaka, Japan
Hiroaki Tanaka , Junya Nishimura , Yuichiro Miki , Tatsuro Tamura , Kazuya Muguruma , Masatsune Shibutani , Go Ohira , Sadaaki Yamazoe , Hisashi Nagahara , Kenjiro Kimura , Takahiro Toyokawa , Ryosuke Amano , Kiyoshi Maeda , Kosei Hirakawa , Masaichi Ohira
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Cancers of the Esophagus and Stomach
Track
Cancers of the Esophagus and Stomach
Sub Track
Translational Research
Citation
J Clin Oncol 36, 2018 (suppl 4S; abstr 62)
DOI
10.1200/JCO.2018.36.4_suppl.62
Abstract #
62
Poster Bd #
F14
Abstract Disclosures
Similar Posters
Poster
2017 Gastrointestinal Cancers Symposium
Gastrectomy after chemotherapy: A new paradigm for the treatment of stage IV gastric cancer.
First Author: Ho Seok Seo
Poster
2013 ASCO Annual Meeting
Cancer-testis antigens in triple-negative and locally advanced breast cancer.
First Author: Samuel John Harris
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Management of nausea and vomiting (N/V) following first-line (1L) zolbetuximab + chemotherapy treatment in claudin-18.2 (CLDN18.2)+, HER2−, locally advanced (LA) unresectable or metastatic gastric or gastroesophageal junction (mG/GEJ) adenocarcinoma: Analysis from the phase 3 SPOTLIGHT and GLOW studies.
First Author: Kohei Shitara
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Impact of PD-L1 expression on survival in patients with unresectable/recurrent gastric cancer receiving first-line chemotherapy without immune checkpoint inhibitors.
First Author: Hidekazu Hirano